Northern Trust’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
Northern Trust's UNCY Position: Q3 2026 in Review
Northern Trust increased its Unicycive Therapeutics (UNCY) stake by 5.8% in Q3 2026, buying an estimated $54.4K and bringing the position to 192,430 shares worth $903K. The position accounts for ﹤0.01% of the portfolio, ranked #3461.
Northern Trust first reported a position in UNCY in Q1 2024 and has held it in 11 quarters since. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- Northern Trust held 192,430 shares of Unicycive Therapeutics worth $903K as of Q3 2026.
- Northern Trust bought 10,500 Unicycive Therapeutics shares in Q3 2026, an estimated $54.4K.
- Unicycive Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #3461 holding.
- Northern Trust first reported a position in Unicycive Therapeutics in Q1 2024 and has held it in 11 quarters since.
- 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.